6.
Ellison-Wright I, Nathan P, Bullmore E, Zaman R, Dudas R, Agius M
. Distribution of tract deficits in schizophrenia. BMC Psychiatry. 2014; 14:99.
PMC: 4108049.
DOI: 10.1186/1471-244X-14-99.
View
7.
Dietsche B, Kircher T, Falkenberg I
. Structural brain changes in schizophrenia at different stages of the illness: A selective review of longitudinal magnetic resonance imaging studies. Aust N Z J Psychiatry. 2017; 51(5):500-508.
DOI: 10.1177/0004867417699473.
View
8.
Makris N, Kennedy D, McInerney S, Sorensen A, Wang R, Caviness Jr V
. Segmentation of subcomponents within the superior longitudinal fascicle in humans: a quantitative, in vivo, DT-MRI study. Cereb Cortex. 2004; 15(6):854-69.
DOI: 10.1093/cercor/bhh186.
View
9.
Bartzokis G, Lu P, Nuechterlein K, Gitlin M, Doi C, Edwards N
. Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia. Schizophr Res. 2007; 93(1-3):13-22.
PMC: 1974878.
DOI: 10.1016/j.schres.2007.02.011.
View
10.
Leroux E, Poirel N, Dollfus S
. Anatomical Connectivity of the Visuospatial Attentional Network in Schizophrenia: A Diffusion Tensor Imaging Tractography Study. J Neuropsychiatry Clin Neurosci. 2020; 32(3):266-273.
DOI: 10.1176/appi.neuropsych.19040101.
View
11.
Lee I, Skerrett P
. Physical activity and all-cause mortality: what is the dose-response relation?. Med Sci Sports Exerc. 2001; 33(6 Suppl):S459-71; discussion S493-4.
DOI: 10.1097/00005768-200106001-00016.
View
12.
Singh R, Bansal Y, Medhi B, Kuhad A
. Antipsychotics-induced metabolic alterations: Recounting the mechanistic insights, therapeutic targets and pharmacological alternatives. Eur J Pharmacol. 2018; 844:231-240.
DOI: 10.1016/j.ejphar.2018.12.003.
View
13.
Keefe R, Bilder R, Davis S, Harvey P, Palmer B, Gold J
. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry. 2007; 64(6):633-47.
DOI: 10.1001/archpsyc.64.6.633.
View
14.
Chen F, Soya H, Yassa M, Li R, Chu C, Chen A
. Effects of exercise types on white matter microstructure in late midlife adults: Preliminary results from a diffusion tensor imaging study. Front Aging Neurosci. 2022; 14:943992.
PMC: 9716128.
DOI: 10.3389/fnagi.2022.943992.
View
15.
Olabi B, Ellison-Wright I, McIntosh A, Wood S, Bullmore E, Lawrie S
. Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biol Psychiatry. 2011; 70(1):88-96.
DOI: 10.1016/j.biopsych.2011.01.032.
View
16.
Loprinzi P, Harper J, Ikuta T
. The effects of aerobic exercise on corpus callosum integrity: systematic review. Phys Sportsmed. 2020; 48(4):400-406.
DOI: 10.1080/00913847.2020.1758545.
View
17.
Alexander A, Lee J, Lazar M, Field A
. Diffusion tensor imaging of the brain. Neurotherapeutics. 2007; 4(3):316-29.
PMC: 2041910.
DOI: 10.1016/j.nurt.2007.05.011.
View
18.
Gurusamy J, Gandhi S, Damodharan D, Ganesan V, Palaniappan M
. Exercise, diet and educational interventions for metabolic syndrome in persons with schizophrenia: A systematic review. Asian J Psychiatr. 2018; 36:73-85.
DOI: 10.1016/j.ajp.2018.06.018.
View
19.
Smith S, Nichols T
. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage. 2008; 44(1):83-98.
DOI: 10.1016/j.neuroimage.2008.03.061.
View
20.
Galderisi S, Kaiser S, Bitter I, Nordentoft M, Mucci A, Sabe M
. EPA guidance on treatment of negative symptoms in schizophrenia. Eur Psychiatry. 2021; 64(1):e21.
PMC: 8057437.
DOI: 10.1192/j.eurpsy.2021.13.
View